the potential of a new , potent , irreversible and selective inhibitor of monoamine oxidase type b , ( e ) -2- ( 3,4-dimethoxyphenyl ) -3-fluorallyamine ( mdl 72145 ) , to augment the effects of l-dopa in an animal model which reproduces the biochemical defect of parkinson 's disease has been evaluated .
C0023570
l-dopa
C0030567
parkinson 's disease